Bodycote (OTCMKTS:BYPLF - Get Free Report)'s share price was up 1.2% during mid-day trading on Thursday . The company traded as high as $8.60 and last traded at $8.60. Approximately 2,816 shares traded hands during mid-day trading, an increase of 2,647% from the average daily volume of 103 shares. The stock had previously closed at $8.50.
Bodycote Stock Performance
The company's fifty day moving average is $7.88 and its 200 day moving average is $7.47.
Bodycote Company Profile
(
Get Free Report)
Bodycote plc provides heat treatment and thermal processing services worldwide. It operates in two business areas, Aerospace, Defence & Energy; and Automotive & General Industrial. The company offers heat treatment services, including altering the microstructure of metals and alloys, such as steel and aluminum to impart properties comprising surface hardness, temperature resistance, ductility, and strength; metal joining services consisting of electron beam welding, HIP diffusion bonding, hydrogen brazing, induction brazing, and furnace/vacuum brazing; and hot isostatic pressing (HIP) services, including isostatic pressing and HIP supporting services, as well as Powdermet technology, a manufacturing process used in the production of complex components using powder metallurgy.
Featured Articles
Before you consider Bodycote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bodycote wasn't on the list.
While Bodycote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.